849093-93-2

Upstream product

• 849093-92-1 2(R)-3-cyclopropylmethylsulfanyl-2-(2,2,2-trifluoro-1(R)-phenyl-ethylamino)propan-1-ol 
• 849093-91-0 2(R)-3-cyclopropylmethylsulfanyl-2-(2,2,2-trifluoro-1(S)-phenyl-ethylamino)propan-1-ol 

Relevant academic research and scientific papers

HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS

The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.